Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT06811038

iCanQuit Smoking Cessation Among Hispanic Adults

Conditions: Cigarette Smoking-Related Carcinoma

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: PHASE3
Enrollment: 854
Sponsor: Fred Hutchinson Cancer Center

Location: Fred Hutch/University of Washington Cancer Consortium Seattle Washington

Summary

This phase III trial compares a smartphone application with or without nicotine replacement therapy in improving smoking cessation among Hispanic adults who would like to quit smoking. The iCanQuit smartphone application focuses on skills for managing urges, motivation, and relapse prevention with personalized quit plans. Nicotine replacement therapy works by giving small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking without any of the other harmful chemicals found in tobacco products.

Eligibility Criteria

Inclusion Criteria: * Self-identify as Hispanic ethnicity * Age 18 and older * Smoking at least one cigarette per day in the past 30 days * Want to quit smoking within 30 days * Interest in learning skills to quit smoking * Willing to be randomly assigned * United States (US) or Puerto Rico (PR) residency for the next twelve months * Have daily access to their own Android or iPhone smartphone * Ability to download a smartphone application (app) * Proficiency in English or Spanish * Not currently (i.e., within past 30 days) using other smoking cessation interventions * Willing to consider using NRT * No previous use of iCanQuit * No household or family member participating * Willingness to complete follow-up assessments at the 3-, 6-, and 12-month follow-ups * Providing email, phone number(s), and mailing address Exclusion Criteria: * NRT CONTRAINDICATION: Heart attack in the last 2 months * NRT CONTRAINDICATION: Stroke in the last 6 months * NRT CONTRAINDICATION: Diagnosed arrhythmia or tachycardia * NRT CONTRAINDICATION: Uncontrolled hypertension * NRT CONTRAINDICATION: Currently using warfarin * NRT CONTRAINDICATION: Pregnant or breastfeeding, or plans to become pregnant during the next 6 months

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06811038). StuddyBuddy aggregates publicly available trial information.